Skip to main content

UBS Group AG

Position in ENSC — Ensysce Biosciences, Inc.

CIK 1610520 ZURICH, V8

Position in ENSC

as of Mar 31, 2026 · filed May 5, 2026
Position Value
$4,738
+$4,646 QoQ
Shares Held
8,791
+8691.0% QoQ
Ownership
0.045%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
20 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ENSC Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS Group AG holds $8,789,675,801 across 560 Biotechnology names.

# Ticker Company Shares Value (USD) Open

All Filings in ENSC

Export CSV
16 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $4,738 8,791
2025-12-31 $92 100
2025-09-30 $1,896 800
2025-06-30 $789 354
2025-03-31 $3,348 1,308
2024-12-31 $4,842 595
2024-09-30 $27,043 112,682
2024-03-31 $9,961 12,610
2023-12-31 $3 3
2023-09-30 $202 147
2023-03-31 $12,358 2,543
2022-12-31 $10,413 13,884
2022-09-30 $11,210 52,142
2022-06-30 $14,831 17,087
2022-03-31 $9,090 7,974
2021-12-31 $46,346 9,861